Search - tctmd.com

Displaying 21 - 40 of 164

Sort: Relevancy | Date

Presentation TCT 2024

Real-World Study of IVL in Challenging BTK Lesions: Acute Results of the Disrupt BTK II Study

Presenter: Sahil Parikh

October 29, 2024

Presentation TCT 2024

TCT 519: Impact of Intravascular Imaging on Clinical Outcomes in the LIFE-BTK Randomized Controlled Trial

Presenter: Hector Garcia-Garcia

October 29, 2024

Presentation TCT 2024

Esprit™ BTK System Device & Data Overview, Real-World Case Discussion and Patient Selection

Presenter: Ethan Korngold

October 28, 2024

Presentation TCT 2024

BTK Drug Coated Balloons: 1 Year After LIFE BTK – We Need Them More Than Ever

Presenter: Peter Schneider

October 28, 2024

Presentation TCT 2024

BTK and BTA: How is Promise II and DVA Making an impact?

Presenter: Anahita Dua

October 28, 2024

Presentation TCT 2024

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Presenter: Brian DeRubertis

October 28, 2024

Presentation TCT 2024

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

Presenter: Sahil Parikh

October 28, 2024

Presentation TCT 2024

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

Presenter: Richard Pin

October 27, 2024

News Industry News

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

June 18, 2024

News Daily News

FDA Approves Bioresorbable Scaffold for BTK Lesions

Michael O'Riordan

April 29, 2024

News Conference News ISET 2024

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

Caitlin E. Cox

January 25, 2024

News Daily News

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

L.A. McKeown

January 19, 2024

News Daily News

Top Endovascular News of 2023

L.A. McKeown

December 28, 2023

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for October 2023

Shelley Wood

November 01, 2023

Presentation TCT 2023

Exemplary Cases From the LIFE-BTK Trial

Presenter: Lawrence Garcia

October 25, 2023

Presentation TCT 2023

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

Presenter: Raghu Kolluri

October 25, 2023

Presentation TCT 2023

LIFE-BTK: The Top Line Results and Beyond

Presenter: Sahil Parikh

October 25, 2023

News Conference News TCT 2023

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

L.A. McKeown

October 25, 2023

Presentation TCT 2023

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

Presenter: Ramon Varcoe

October 25, 2023

Presentation TCT 2023

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

Presenter: Lawrence Garcia

October 25, 2023

Advertisement

Real-World Study of IVL in Challenging BTK Lesions: Acute Results of the Disrupt BTK II Study

TCT 519: Impact of Intravascular Imaging on Clinical Outcomes in the LIFE-BTK Randomized Controlled Trial

Esprit™ BTK System Device & Data Overview, Real-World Case Discussion and Patient Selection

BTK Drug Coated Balloons: 1 Year After LIFE BTK – We Need Them More Than Ever

BTK and BTA: How is Promise II and DVA Making an impact?

BTK Scaffolds: 1 Year After LIFE BTK – The Landscape is Shifting

Cost Effectiveness of Drug-Eluting Resorbable Scaffold Versus Angioplasty for Infrapopliteal Artery Disease From the LIFE-BTK Trial

TCT 26: Pharmacokinetic Profile of Everolimus Eluted From the Esprit BTK Scaffold: Data From the LIFE-BTK Pharmacokinetics Sub-Study

Cordis Announces Positive 24-Month Results from Superficial Femoral Artery Study, Confirming Sustained Benefits of SELUTION SLR™ (sustained limus release) Drug-Eluting Balloon in Complex Patients

FDA Approves Bioresorbable Scaffold for BTK Lesions

Tack Works Well in Dissection Repair of Complex Lesions: TOBA II BTK

New Scientific Statement Focuses on Below-the-Knee Technical Challenges

Top Endovascular News of 2023

TCTMD’s Top 10 Most Popular Stories for October 2023

Exemplary Cases From the LIFE-BTK Trial

Essential Features of the Core Laboratory Protocols: Lessons Worth Learning

LIFE-BTK: The Top Line Results and Beyond

LIFE-BTK: Bioresorbable Scaffold Holds Promise for Infrapopliteal CLTI

Primary Outcomes of the Esprit™ BTK Drug-Eluting Resorbable Scaffold for the Treatment of Infrapopliteal Lesions: The LIFE-BTK Randomized Controlled Trial

Keynote Lecture: Innovation in BTK Intervention: Clinical and Technical Lessons Learned From Recent DCB and DES Trials

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content